The unique nature of fatigue in multiple sclerosis: prevalence, pathophysiology, contributing factors and subjective experience

Physical Therapy Reviews

Volumn 12, Issue 1, 2007, Pages 43-51

  Smith, Cath ^a   Hale, Leigh ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

CANCER; FATIGUE; HUMAN IMMUNOVIRUS AUTOIMMUNE DEFICIENCY SYNDROME; MULTIPLE SCLEROSIS; PARKINSON'S DISEASE

Indexed keywords

EID: 70749084018     PISSN: 10833196     EISSN: 1743288X     Source Type: Journal    
DOI: 10.1179/108331907X174970     Document Type: Review

References (65)

1. Chaudhuri A, Behan PO. Fatigue and the basal ganglia. J Neurol Sci 2000;179:34–42
2. Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson Fatigue Scale. Parkinsonism Relat Disord2005;11:49–55
3. Winningham ML. Strategies for managing cancer-related fatigue. Cancer 2001;92:988–97
4. Sullivan PS, Dworkin MS. Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symptom Manage 2003;25:329–33
5. Schwid SR, Covington BS, Segal BM, Goodman AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 2002;39:211–24
6. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984;65:135–8
7. Friedman J, Friedman H. Fatigue in Parkinson’s disease. Neurology 1993;43:2016–8
8. Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Cielito C, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression and community dwelling adults. J Pain Symptom Manage 2003;25:307–18
9. Krupp LB, LaRocca NG, Muir-Nash J, Steinburg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosis. Arch Neurol 1989;46:1121–3
10. Fisk JD, Pontefract A, Rivto PG. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994;21:9–14
11. Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik S. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage 1998;15:159–67
12. Iriarte J, Subira ML, de Castro P. Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Mult Scler 2000;6:124–30
13. Miller AH. Cytokines and sickness behaviour: implications for cancer care and control. Brain Behav Immun 2002;17:S132–4
14. Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Amman W, et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A18 F-fluorodeoxyglucose positron emission tomography study. Neurology 1997;48:1566–71
15. Tartaglia MC, Narayanan S, Francis S, Santos A, De Stefano N, Lapierre Y, et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 2004;61:201–7
16. Siegal K, Bradley C, Lekas HM. Causal attributions for fatigue among late middle-aged and older adults with HIV infection. J Pain Symptom Manage 2004;28:211–24
17. De Groot MH, Phillips SJ, Eskes GA. Fatigue associated with stroke and other neurologic conditions: Implications for stroke rehabilitation. Arch Phys Med Rehabil 2003;84:1714–20
18. Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 2003;17:225–34
19. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 2003;9:219–27
20. Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 1999;4:1–10
21. Branas P, Jordan R, Fry-Smith A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000;4:1–52
22. Murray TJ. Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci 1985;12:251–4
23. Karlsen K, Larsen JP, Tandberg E, J0rgensen K. Fatigue in patients with Parkinson’s disease. Move Disord 1999;14:237–41
24. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson’s disease - the Fatigue Severity Scale. Eur J Neurol 2002;9:595–600
25. Smets EMA, Grassen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315–25
26. Theobald DE. Cancer pain, fatigue, distress and insomnia in cancer patients. Clin Cornerstone 2004;6(Suppl 1D):15–21
27. Groopman JE. Fatigue in cancer and HIV/AIDS. Oncology (Williston Park) 1998;12:335–44
28. Ferrando S, Evans S, Goggin K, Sewell M, Fishman B, Rabkin J. Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosom Med 1998;60:759–64
29. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001;92:1684–8
30. Marrie RA, Fisher E, Miller DM, Lee JC, Rudick RA. Association of fatigue and brain atrophy in multiple sclerosis. J Neurol Sci 2005;228:161–6
31. Liepert J, Mingers D, Heeson C, Baumer T, Weiller C. Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler 2005;11:316–21
32. Klein RC, de Jong BM, de Vries JJ, Leenders KL. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson’s disease. Move Disord 2005;20:1021–30
33. Bergner M, Bobbit RA, Pollard WE, Martin DP, Gilson BS. The Sickness Impact Profile: validation of a health status measure. Med Care 1976;14:56–67
34. Berardelli A, Rona S, Inghilleri M, Manfredi M. Cortical inhibition in Parkinson’s disease: a study with paired magnetic stimulation. Brain 1996;119:71–7
35. Giovannoni G, Thompson AJ, Miller DH, Thompson EJ. Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology 2001;57:676–81
36. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? Cancer 2003;97:2919–25
37. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henscel K, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000;6:181–5
38. Kroencke DC, Lynch S, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability and disease pattern. Mult Scler 2000;6:131–6
39. Dimeo F, Stieglitz R, Novelli-Fischer U, Fetscher S, Mertelsmann R, Keul J. Correlation between physical performance and fatigue in cancer patients. Ann Oncol l997;8:1251–5
40. Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression and lesion site in patients with multiple sclerosis. Arch Neurol 1992;49:641–3
41. Friedman JH, Chou KL. Sleep and fatigue in Parkinson’s disease. Parkinsonism Relat Disorder 2004;10:S27–35
42. Petajan J, Gappmaier E, White A, Spencer M, Mino L, Hicks R. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39:432–41
43. Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson’s disease. Neurology 2003;60:1119–24
44. Munro BH, Visintainer MA, Page EB. Statistical methods for health care research. Philadelphia, PA: Lippincott, 1986
45. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale. Neurology 1983;33:1444–52
46. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62
47. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71
48. World Health Organization. International Classification of Functioning, Disability and Health. 2001
49. Barroso J, Sandelowski M. In the field with the Beck Depression Inventory. Qual Health Res 2001;11:491–504
50. Lewi PJ, Pinchard AG. An automated Minnesota Multiphasic Personality Inventory test. Acta Psychol 1967;26:397–9
51. Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 2004;61:525–8
52. Iriarte J, Katsamakis G, de Castro P. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 1999;5:10–6
53. Johns MW, A new method for measuring daytime sleepiness. The Epworth Sleepiness Scale. Sleep 1991;14:540–5
54. Mendoza TR, Wang XS, Cleeland CS The rapid assessment of fatigue severity in cancer patients - use of the Brief Fatigue Inventory. Cancer 1999;85:1186–96
55. Lashley FR. A review of sleep in selected immune disorders and autoimmune disorders. Holist Nurs Pract 2003;17:65–80
56. Darko DF, McCutchan JA, Kripke DF, Gillin JC, Golshan S., Fatigue, sleep disturbance, disability and indices of progression of HIV infection. Am J Psychiatry 1992;149:514–20
57. Darko DF, Mitler MM, Miller JC. Growth Hormone, fatigue, poor sleep, and disability in HIV infection. Neuroendocrinology 1998;67:317–24
58. Gladson B. Pharmacology for Physical Therapists. St Louis, MO: Elsevier Saunders, 2006
59. Ponichtera-Mulcare J, Mathews T, Barret PJ, Gupta S. Changes in aerobic fitness of patients with multiple sclerosis during a six month training program. Sports Med Training Rehabil 1997;7:265–72
60. Petajan JH, White AT. Recommendations for physical activity in patients with multiple sclerosis. Sports Med 1999;27:179–91
61. Ponichtera-Mulcare J. Exercise and multiple sclerosis. J Med Sci Sports Exer 1993;25:451–65
62. Stuifbergen AK, Rogers S. The experience of fatigue and strategies of self care among persons with multiple sclerosis. Appl Nurs Res 1997;10:2–10
63. Flensner G, Ek AC, Söderhamn M. Lived experience of MS- related fatigue - a phenomenological interview study. Int J Nurs Stud 2003;40:707–17
64. Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Move Disord 2001;16:190–6
65. Barsevick AM, Whitmer K, Walker L. In their own words: using the Common Sense Model to analyze patient descriptions of cancer-related fatigue. Oncol Nurs Forum 2001;28:1363–9